Cleared Traditional

K173107 - Vios Central Station Monitor Software

K173107 is an FDA 510(k) clearance for Vios Central Station Monitor Software, manufactured by Vios Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DXJ cleared through the Traditional 510(k) pathway after a 300-day FDA review.

K173107 · Vios Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
300d
Days
Class 2
Risk

K173107 is an FDA 510(k) clearance for the Vios Central Station Monitor Software, Vios Central Server Software. Classified as Display, Cathode-ray Tube, Medical (product code DXJ), Class II - Special Controls.

Submitted by Vios Medical, Inc. (St. Paul, US). The FDA issued a Cleared decision on July 26, 2018 after a review of 300 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vios Medical, Inc. devices

FDA 510(k) Submission Details - K173107

510(k) Number K173107 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date July 26, 2018
Days to Decision 300 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
175d slower than avg
Panel avg: 125d · This submission: 300d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXJ Device Classification - Class 2, Special Controls

Product Code DXJ Display, Cathode-ray Tube, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXJ Display, Cathode-ray Tube, Medical

All 60
Devices cleared under the same product code (DXJ) and FDA review panel - the closest regulatory comparables to K173107.
ESSENZ Patient Monitor
K212003 · Livanova Deutschland, GmbH · Nov 2021
Philips IntelliVue GuardianSoftware (Rev. E.0X)
K212208 · Philips Medizin Systeme Boeblingen GmbH · Sep 2021
Essence 55SP Large Monitor System
K201162 · Shenyang Torch-Bigtide Digital Technology Co., Ltd. · Aug 2020
Philips IntelliVue GuardianSoftware
K180534 · Philips Medizin Systeme Boeblingen GmbH · Jul 2018
Nexxis OR
K173381 · Barco N.V. · Feb 2018
Essence 55S Large Monitor System
K172969 · Shenyang Torch-Bigtide Digital Technology Co., Ltd. · Jan 2018